Xcounter Share Discussion Threads

[buystock] 14/3/2010 07:20

21
Posts: 804 margic21

Answer
Opinion: Strong Buy
Price: 6.00
artemis..4 Mar '10

was on the phone to a member of staff today... been in contact via email... they say there application has taken longer as it has been viewed as a business loan as opposed to a grant... however, although they will not release and price sensitive information they did comment... ' Mr ioannou (me).. we believe we will get the result we had expected before considering any form of application, and will be informing all relevant associates of our plans once we have received official conformation.. we expect to be working closer to the mention company (xct) within 2 weeks and possible much sooner.' i could only buy 25 thousand shares and as you can see they have yet to appear on any market.. but are in my account and im now very excited.. i soon expect to see a news release or two followed by a re-rating within 3 months... for me this is a huge multi-bagger and i dont often set a recommendation on a stock.. but i cannot believe this is falling under the radar... but happy to be invested and see 30p a easy target short term.... people will be missing this one

[buystock] 13/3/2010 17:00

THE NEW /ajat art cdt sensor now on sale through f1fimet. IntraOS 70 - intra-oral x-ray unit for traditional and digital pictures; wall mounted, 70kV, short/medium/long arm page 1
page 2 £1,850.00
IntraOS 70 - intra-oral x-ray unit for traditional and digital pictures; mobile, 70kV page 1
page 2 £1,950.00
IntraOS 70 DG - intra-oral x-ray unit designed specifically for digital images - 0.4 focal spot; wall mounted brochure £TBA
extra-oral OPG (traditional)
PantOS 16 Xp - traditional OPG brochure £10,490.00
PantOS 16 Xp Ceph - traditional OPG with cephalometric arm £12,990.00
extra-oral OPG (digital)
PantOS Dg Xp - digital OPG brochure £16,990.00
NEW PantOS Dg Xp Ceph - digital OPG with cephalometric arm, product launched at the International Dental Show 2009 in Cologne, unbeatable price for a digital, panoramic x-ray unit with cephalometric arm, image size: panoramic 3580 x 1535 pix, ceph 5300 x 4608 pix brochure £24,990.00

[buystock] 13/3/2010 16:26

jonno have you been in these before or just taking an interest there,s loads of stuff expected and this could be the month with clinical test results from last year on 3dt mammo and artemis taling us forward.gl this is an excellent entry point all time low/fully funded and when artemis sign a new agreement.wowzaa . Artemis has applied for a €2.8m grant from the German government (Bundesministerium für Bildung und Forschung) to fund half of the project. It is currently anticipated that the German government will announce the results of the grant application on or around 26 January 2010. NOT HEARD YET PIVOTAL


If Artemis' application for the grant is successful, the Company anticipates negotiating and signing a co-development agreement with Artemis in the first quarter of 2010 which will include provisions granting Artemis exclusivity for the PCT technology for the Mammo CT application. Following the developmental phase, Artemis proposes to licence the product to a major OEM and it is XCounter's current intention at that time to enter into a supply agreement with Artemis, so as to exclusively manufacture and supply the detector components to be integrated into the completed Mammo CT device. AJAT profit making The AJAT acquisition has exceeded the Board's expectations regarding profit and is in line with expectations for revenues in the first six months since completion. Exciting new orders, especially within industrial applications, strengthens the Group's business pipeline in both the short and medium term.


In the 12 months ended 31 August 2009, AJAT reported operating profit of €414,000 (unaudited) and total revenues of approximately €3.5m (unaudited). These revenues came largely from dental and industrial applications. AJAT's detectors are integrated by OEMs in different system applications, spanning from dental panoramic cephalometry, and 2D and future 3D medical imaging. In addition, since its launch in August 2008, AJAT's dental 2D end-user system "Art Plus" has sold 86 units.


AJAT is a profitable business with high growth opportunities within its core dental applications but also within the field of industrial applications such as inspection systems for food production, inspections of welds for the oil and gas piping industry and small animal imaging for the pharmaceutical industry. The Directors believe that AJAT will generate revenues of €4 million and EBITDA of approximately €550,000 (14 per cent. of sales) during the 12 months ending 31 December 2009, a 13 per cent. increase on revenues for the 12 months ended 31 December 2008.

[buystock] 13/3/2010 10:12

should start too see major recovery just unloved and hidden away jonno forget the spread 5.7-6.5

[buystock] 12/3/2010 07:55

JONNO loads of news due german grant 2.8m was due on the 26th jan 2010 we are fully funded and artemis will push this on im sure with a new agreement.not long now up yesterday on plus.massive drop on funding issues now sorted instutions taking a holding read the holding rns news.everything gearing up for .HERE.Forecast Key Dates Key Date Status Date
Next annual report due Unconfirmed 25th March 2010
Next prelim announcement Unconfirmed 25th March 2010

[jonno1] 11/3/2010 20:18

Never bought this one Buystock, terrible spread...still dead I see, why no interest?

[buystock] 11/3/2010 17:15

A BIT OF BUYING PR-RESULTS AND ARTEMIS deal.

[buystock] 11/3/2010 14:09

up 18% on plus

[buystock] 09/3/2010 15:07

Published by admin on 18 Nov 2009 at 04:19 pm It is a snapshot of the page as it appeared on 20 Dec 2009 18:04:56 GMT

Panoramic Digital X ray Retrofit kit for Soredex Cranex
Retropan Kit Contents: Belmont X-Caliber Soredex Cranex. Posted by admin on November 18th, 2009 filed in Digital. With AJAT's SCAN300FP retrofit kit, an existing Panoramic System is equipped with the When the SCAN300FP camera is integrated with a Panoramic X-Ray unit, From the end user's point of view, the SCAN300FP acts as a digital film cassette. Technical Article Abstract ProMax Digital Panoramic and Pan/Ceph X-rays ProMax Panoramic Digital X ray Retrofit kit for Soredex Cranex Lasico Filar. X RAY ANY SENSOR SISTEMA DIGITAL RADIOVIIOGRAFIA $2300.00 Retropan kits are also available for Siemens OP 10, Soredex/Cranex, Click the button below to add the Panoramic Digital Retrofit kit PC1000 to your wish list. Soredex Scan from Digora PCT or Optime Scanners or Cranex D direct digital pan/ceph. We offer seamless integration with 11 different digital X-ray products from 7 retrofit, Soredex Cranex 2.5 & 3- (Kit comes direct from Soredex). Panoramic Digital X-ray Retrofit kit for Soredex Cranex.

Panoramic Digital X-ray Retrofit kit for Soredex Cranex Buy from eBay Top-rated sellers and get excellent service and. soredex cranex d digital panoramic x-ray cranexd Buy from eBay Top-rated sellers and get excellent service and. Retropan equiped Panorex units capture direct digital x-ray images and therefore offer essentially the same features and benefits as new. Panoramic Digital X-ray Retrofit kit for Soredex Cranex This offer is for a Retropan ((digital X-ray retrofit kit) for the Panoramic Corp PC 1000 not the PC 1000 itself. Panoramic Digital X-ray Retrofit kit for Soredex Cranex $12995.00 · DENTAL IMPRESSION HIGH PERFORMANCE MIXING TIP BLUE COMB. Crosstex International Instrumentarium/Soredex · Cranex® Novus Digital Panoramic X-ray, $750.00 Orthopantomograph® OP200 D/ OC200 D Digital Panoramic X-ray with VT, $1500.00 Porter/Brown Retrofit Scavenger Rubber Goods Package, $249.00. panoramic-digital-x-ray-retrofit-kit-for-soredex- · Panoramic Digital X-ray Retrofit kit for Soredex Cranex US $12995.00 (0 Bid) Bid now | Buy it now |.

Retrofit your existing Pan, why purchase new Digi-Pan? Panoramic Digital X-ray Retrofit kit for Soredex Cranex. Retrofit your existing Pan, why purchase new Digi-Pan? PC and used with other components in our CDR Pan kit to acquire panoramic images. Synergy D6 Welcome Kit Tips/ Welcome Kit Syringes, $300.00. 2009: Diagnostix x-ray2go- New portable x-ray unit, OEM from Korea with dental and vet applications. 2 X PORTABLE TRAVEL KIT CHARGER FOR APPLE iPHONE 3G 3GS. Panoramic Digital X ray Retrofit kit for Soredex Cranex · Stryker SE 5 TPS Arthroscopy Endoscopy Shaver Surgical · Turbo 7000 ENT Shaver & Drill system. Retropan is an aftermarket film replacement kit for panoramic x-ray devices.

[buystock] 09/3/2010 15:06

STILL only 9-11% in free float placing shares taken up our imminent prof/new industrial partner/ARTEMIS.Artemis and its founder, Prof. Kalender, have substantial expertise and a proven track record in CT physics, system and applications development. It intends to develop, validate, clinically test and commercialize a low-dose, high-resolution breast CT scanner using the XCounter photon counting digital direct conversion solid state detector technology.


Co-development of the breast CT scanner provides a cost effective way for XCounter to progress the development of the detector technology as, under the current proposals, Artemis intends to provide €1.75m over a period of two years during the R&D phase of the project. Artemis would fund XCounter's detector development in return for exclusivity for the PCT technology in the Mammo CT application.


Artemis has applied for a €2.8m grant from the German government (Bundesministerium für Bildung und Forschung) to fund half of the project. It is currently anticipated that the German government will announce the results of the grant application on or around 26 January 2010.


If Artemis' application for the grant is successful, the Company anticipates negotiating and signing a co-development agreement with Artemis in the first quarter of 2010 which will include provisions granting Artemis exclusivity for the PCT technology for the Mammo CT application. Following the developmental phase, Artemis proposes to licence the product to a major OEM and it is XCounter's current intention at that time to enter into a supply agreement with Artemis, so as to exclusively manufacture and supply the detector components to be integrated into the completed Mammo CT device. AJAT profit making The AJAT acquisition has exceeded the Board's expectations regarding profit and is in line with expectations for revenues in the first six months since completion. Exciting new orders, especially within industrial applications, strengthens the Group's business pipeline in both the short and medium term.


In the 12 months ended 31 August 2009, AJAT reported operating profit of €414,000 (unaudited) and total revenues of approximately €3.5m (unaudited). These revenues came largely from dental and industrial applications. AJAT's detectors are integrated by OEMs in different system applications, spanning from dental panoramic cephalometry, and 2D and future 3D medical imaging. In addition, since its launch in August 2008, AJAT's dental 2D end-user system "Art Plus" has sold 86 units.


AJAT is a profitable business with high growth opportunities within its core dental applications but also within the field of industrial applications such as inspection systems for food production, inspections of welds for the oil and gas piping industry and small animal imaging for the pharmaceutical industry. The Directors believe that AJAT will generate revenues of €4 million and EBITDA of approximately €550,000 (14 per cent. of sales) during the 12 months ending 31 December 2009, a 13 per cent. increase on revenues for the 12 months ended 31 December 2008.

[buystock] 08/3/2010 15:59

Co-development of the breast CT scanner provides a cost effective way for XCounter to progress the

development of the detector technology as, under the current proposals, Artemis intends to provide €1.75m

over a period of two years during the R&D phase of the project. Artemis would fund XCounter's detector

development in return for exclusivity for the PCT technology in the Mammo CT application.

Artemis has applied for a €2.8m grant from the German government (Bundesministerium für Bildung und

Forschung) to fund half of the project. It is currently anticipated that the German government will announce

the results of the grant application on or around 26 January 2010.

If Artemis' application for the grant is successful, the Company anticipates negotiating and signing a co-

development agreement with Artemis in the first quarter of 2010 which will include provisions granting

Artemis exclusivity for the PCT technology for the Mammo CT application. Following the developmental

phase, Artemis proposes to licence the product to a major OEM and it is XCounter's current intention at that

time to enter into a supply agreement with Artemis, so as to exclusively manufacture and supply the detector

components to be integrated into the completed Mammo CT device.

The Directors believe that the total initial market for the complete Mammo

CT systems to be €150m per annum

[buystock] 08/3/2010 15:57

XCT -3T Tomosynthesis - Product Pipeline
XCounter has submitted a total of 54 patent families. The patents cover completely new sensing technologies that are substantially different from those used in today's traditional medical X-ray technologies.

The XC Mammo -3T is the first system in a pipeline of devices planned to commercially exploit the XCounter technology. Deployment of the XC Mammo -3T into the clinic will complete a key step toward targeting other imaging applications in whole-body imaging, as well as imaging support for therapy and interventional procedures.

The XCT -3T technology has the potential to impact the medical imaging market via complementary and improved diagnostic tools and early, proactive clinical examinations for cancer, stroke and heart disease.

Also, future XCT -3T-based systems may have the potential to expand the pre-symptomatic screening market to include not only 3D mammography (digital breast tomosynthesis), but also lung, colon, prostate, whole-body and cardiac screening.

Our patents protect a series of product pipelines beyond the product platforms presently prioritised. Also, the patents do not only cover new sensing technologies in medical imaging, they also cover new application areas outside medical imaging made possible by our proprietary technology.

[buystock] 08/3/2010 15:52

GOZ ADDED TODAY will be accumulating as much as possible.Subject: BUY 30000 XCT executed @ 6.20 GBX March 08, 2010 09:03 AM UK
Your Market order xxxxxxxxx to BUY 30000 XCT (Xcounter AB) has been executed at 6.20 GBX

[goz1986] 13/2/2010 14:15

oh another buystock ramp......

[egoi] 29/1/2010 12:55

Anyone interested in Breast Scanners might like to look at Specialty Scanners on plus-Quoted which has a fully developed MRI machine - and a market cap about 50 times LESS (at 750k) than XCT!

Exciting progress there today:

Not in the numbers (though the 1.6 million grant should keep them on a sound financial footing for the foreseeable future imho, and the market cap at 750k remains way below net assets) but it looks to me as though commercialisation is one potentially large step nearer for Specialty Scanners (Plus:SCAN)

I'm interested most, by the apparently dull bit.

It looks like the decks are being cleared, and with net assets way above the market cap, hopefully at a level that will more than satisfy existing shareholders. I can see why the price has been marked up - at this level if I was a market maker I would certainly be interested in being 'long' of this stock now.

'4. That Clause 6 formerly contained in the Company's Memorandum of Association
(statement of authorised share capital) be and is hereby deleted so that
the Company's Articles of Association shall no longer contain any
restriction with respect to the maximum share capital which may be allotted
thereunder.'

The clue might lie here:

"At the time of writing, the Company is continuing to evaluate proposals from several institutions interested in participating in the Company's commercialisation programme, including interest from major international medical equipment manufacturers for forming business relationships in several areas."

In what I'd somewhat tongue in cheek, after ten years of development, call 'SCAN speak', I view the move to increasing the shares as a significant acknowledgement that the board at last accept that biting the commercialisation bullet by enlarging the company, the time is imminent.

Of course such enlargement will bring new risks, but also imho from the 750k market cap, the real possibility of a genuinely exciting ride for shareholders.

Rsults and AGM announcements can be read here:





And more information and data on the company itself here:



This is the company website:

[buystock] 25/1/2010 14:19

26th jan news close XCT -3T Tomosynthesis - Product Pipeline
XCounter has submitted a total of 54 patent families. The patents cover completely new sensing technologies that are substantially different from those used in today's traditional medical X-ray technologies.

The XC Mammo -3T is the first system in a pipeline of devices planned to commercially exploit the XCounter technology. Deployment of the XC Mammo -3T into the clinic will complete a key step toward targeting other imaging applications in whole-body imaging, as well as imaging support for therapy and interventional procedures.

The XCT -3T technology has the potential to impact the medical imaging market via complementary and improved diagnostic tools and early, proactive clinical examinations for cancer, stroke and heart disease.

Also, future XCT -3T-based systems may have the potential to expand the pre-symptomatic screening market to include not only 3D mammography (digital breast tomosynthesis), but also lung, colon, prostate, whole-body and cardiac screening.

Our patents protect a series of product pipelines beyond the product platforms presently prioritised. Also, the patents do not only cover new sensing technologies in medical imaging, they also cover new application areas outside medical imaging made possible by our proprietary technology.

[buystock] 25/1/2010 11:46

all buys 25/01/2010 08:18:38 8.50 5,000 O 425.00
22/01/2010 11:48:30 8.50 29,148 O 2,477.58
22/01/2010 11:05:07 8.50 50,000 O 4,250.00
22/01/2010 11:03:09 8.50 50,000 O 4,250.00
22/01/2010 10:59:26 8.50 8,312 O 706.52
20/01/2010 09:38:50 8.50 12,000 O 1,020.00
19/01/2010 08:08:40 8.50 21,443 O 1,822.66
18/01/2010 14:29:04 9.00 29,358 O 2,642.22
18/01/2010 10:31:49 9.00 5,417 O 487.53
18/01/2010 08:04:15 9.00 10,923 O 983.07
15/01/2010 15:18:48 6.00 26,425 O 1,585.50
15/01/2010 14:51:56 9.00 55,062 O 4,955.58
15/01/2010 10:53:49 9.00 5,417 O 487.53
15/01/2010 10:40:31 9.00 5,555 O 499.95
15/01/2010 10:38:43 9.00 10,000 O 900.00
14/01/2010 12:35:35 8.00 7,307 O 584.56
14/01/2010 12:30:17 8.00 1,875 O 150.00
14/01/2010 12:27:01 8.00 466 O 37.28
14/01/2010 12:18:39 8.00 4,365 O 349.20
14/01/2010 11:48:42 8.00 5,000 O 400.00
14/01/2010 11:48:18 8.00 5,000 O 400.00
14/01/2010 11:22:24 8.00 5,000 O 400.00

[buystock] 25/1/2010 11:40

artemis oem news due watch the video

[buystock] 25/1/2010 07:47

wait for the A.A BUY.Co-development of the breast CT scanner provides a cost effective way for XCounter to progress the
development of the detector technology as, under the current proposals, Artemis intends to provide €1.75m
over a period of two years during the R&D phase of the project. Artemis would fund XCounter's detector
development in return for exclusivity for the PCT technology in the Mammo CT application.
Artemis has applied for a €2.8m grant from the German government (Bundesministerium für Bildung und
Forschung) to fund half of the project. It is currently anticipated that the German government will announce
the results of the grant application on or around 26 January 2010.
If Artemis' application for the grant is successful, the Company anticipates negotiating and signing a co-
development agreement with Artemis in the first quarter of 2010 which will include provisions granting
Artemis exclusivity for the PCT technology for the Mammo CT application. Following the developmental
phase, Artemis proposes to licence the product to a major OEM and it is XCounter's current intention at that
time to enter into a supply agreement with Artemis, so as to exclusively manufacture and supply the detector
components to be integrated into the completed Mammo CT device.
The Directors believe that the total initial market for the complete Mammo
CT systems to be €150m per annum.

[argy2] 25/1/2010 07:20

Sounds more like seller or MMs have a lot of stock to unload.

[buystock] 25/1/2010 06:34

26th draws close looks 150k@7.5p was a director buy or institutions after hours nobody else gets them that cheap.

[buystock] 23/1/2010 07:48

busy week coming